Author details

Full Name

David J Konieczkowski

Affiliation

ORCID

Career Start Year

2004

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36980667	Disparities in Survival Outcomes among Racial/Ethnic Minorities with Head and Neck Squamous Cell Cancer in the United States.		2023
36369098	Prognostic factors in patients receiving surgery and radiation therapy for retroperitoneal sarcoma: A machine-learning analysis.	Surgery	2023
37658906	Radiation-associated secondary malignancies: a novel opportunity for applying immunotherapies.		2023
38001708	Factors Associated with Total Laryngectomy Utilization in Patients with cT4a Laryngeal Cancer.		2023
37996341	Preoperative radiation therapy increases adherence in patients with high-risk extremity soft tissue sarcoma.		2023
36583477	Disparities in survival outcomes among Black patients with HPV-associated oropharyngeal cancer.		2023
37460363	Robust VMAT treatment planning for extremity soft tissue sarcomas.		2023
36555172	Association between Tumor Microbiome and Hypoxia across Anatomic Subsites of Head and Neck Cancers.		2022
35512990	List Prices for Proton Radiation Therapy.	Practical Radiation Oncology	2022
35121878	Integrating molecular profiles into clinical frameworks through the Molecular Oncology Almanac to prospectively guide precision oncology.	Nat Cancer	2021
33958151	Contemporary and Emerging Approaches to Bladder-Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer.	Hematology/Oncology Clinics of North America	2021
33866554	Low-dose preoperative radiation, resection, and reduced-field postoperative radiation for soft tissue sarcomas.	J Surg Oncol	2021
33208343	Identification of a Synthetic Lethal Relationship between Nucleotide Excision Repair Deficiency and Irofulven Sensitivity in Urothelial Cancer.	Clin Cancer Res	2021
32147017	Radiation Strategies for Spine Chordoma: Proton Beam, Carbon Ions, and Stereotactic Body Radiation Therapy.	Neurosurgery Clinics of North America	2020
29763622	A Convergence-Based Framework for Cancer Drug Resistance.	Cancer Cell	2018
28837809	Decomposing Oncogenic Transcriptional Signatures to Generate Maps of Divergent Cellular States.	Cell Syst	2017
27088724	Characterizing genomic alterations in cancer by complementary functional associations.	Nat Biotechnol	2016
24771846	A melanoma cell state distinction influences sensitivity to MAPK pathway inhibitors.	Cancer Discov	2014
22847744	Resistance to EGFR blockade in colorectal cancer: liquid biopsies and latent subclones.	Cell Res	2013
22589389	MicroSCALE screening reveals genetic modifiers of therapeutic response in melanoma.	Sci Signal	2012
20570916	Fine-mapping in African Americans of 8 recently discovered genetic loci for plasma lipids: the Jackson Heart Study.	Circ Cardiovasc Genet	2010
19395640	Mutations in zebrafish leucine-rich repeat-containing six-like affect cilia motility and result in pronephric cysts, but have variable effects on left-right patterning.	Development	2009
14736876	A WT1 co-regulator controls podocyte phenotype by shuttling between adhesion structures and nucleus.	J Biol Chem	2004